October 27, 2021
2 mins read

No approval for Covaxin yet, WHO seeks clarifications

The WHO said it expects to receive these clarifications from Bharat Biotech by the end of this week…reports Asian Lite News.

The World Health Organisation (WHO) on Tuesday said “additional clarifications” are needed from Bharat Biotech regarding its Covid-19 vaccine ‘Covaxin’ for a final “risk-benefit assessment” before recommending the vaccine for emergency use.

“The Technical Advisory Group for Emergency Use Listing (TAG-EUL) is an independent advisory group that provides recommendations to WHO on whether a Covid 19 vaccine can be listed for emergency use under the EUL procedure,” the WHO said.

“The TAG met today (October 26, 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine,” the WHO said.

The WHO said it expects to receive these clarifications from Bharat Biotech by the end of this week.

“The TAG expects to receive these clarifications from the manufacturer by the end of this week, and aims to reconvene for the final risk-benefit assessment on Wednesday, November 3,” the WHO said.

Last week, the WHO had said it is expecting one “additional piece” of information from Bharat Biotech regarding Covaxin. The WHO said there needs to be a thorough evaluation to ensure vaccines are safe and “cannot cut corners” before it is recommended for emergency use.

“We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #Covid-19 Emergency Use Listing, but we cannot cut corners – before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” the WHO said in a tweet on October 18.

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine’s Emergency Use Listing (EUL).

India’s first indigenous Covid-19 vaccine, Covaxin, demonstrated 77.8 per cent efficacy in its Phase 3 clinical trial.

In June, Bharat Biotech said it concluded the final analysis of Covaxin efficacy from Phase 3 trials. The Covaxin jab has been approved in 14 countries and 70 million doses have been distributed overseas, Bharat Biotech told WHO.

Bharat Biotech’s Covaxin and AstraZeneca and Oxford University’s Covishield are the two widely used vaccines in India.

The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and Sinopharm for emergency use.

ALSO READ-Covaxin gets emergency use approval for kids aged 2-18 years

READ MORE-WHO’s nod for Covaxin delayed again over technical queries

Previous Story

Israel and Lebanon urged to respect the Blue Line

Next Story

Saudi Arabia To Resume Fund To Pakistan

Latest from -Top News

Harvard sues Trump over foreign students ban

Harvard University has filed a federal lawsuit against the Trump administration after being barred from enrolling international students, marking its second legal challenge in a month against what it describes as politically

Pakistan may face stricter IMF terms

The International Monetary Fund (IMF) will undertake its next funding review for Pakistan in the second half of 2025, with 11 new conditions now attached to the continuation of its Extended Fund

Indian diaspora in Japan backs Operation Sindoor

Members of the Indian diaspora in Japan have strongly endorsed Operation Sindoor, India’s targeted military response to the April 22 terror attack in Pahalgam, Kashmir, praising Prime Minister Narendra Modi’s leadership and

WHO adopts Global Pandemic Agreement

The agreement seeks to boost international coordination and ensure equitable access to life-saving tools during future pandemics, while reaffirming respect for national sovereignty in public health decisions In a move aimed at
Go toTop

Don't Miss

India shines bright as nation engulfs in Diwali festivities  

People in Kolkata, Thoothukudi, Bathinda, Lucknow, Aligarh, Nellore, Pune, Hyderabad,

UK govt looks to strengthen partnership with Indian varsities

On Monday, British Council’s India director, Alison Barrett, said that